We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNGR:NASDAQFingerMotion, Inc. Analysis

Data as of 2026-04-04 - not real-time

$1.02

Latest Price

8/10Risk

Risk Level: High

Executive Summary

FingerMotion, Inc. is trading around $1.02, barely above its 52‑week low of $0.92 and well below its 20‑day SMA of roughly $1.16, signaling a price that is struggling to regain momentum. The technical picture is bearish, with a MACD histogram in negative territory and a decreasing volume trend that underscores waning buying interest. RSI hovers just below the 50‑point midpoint, suggesting limited upside and modest downside pressure. Volatility is extreme, with a 30‑day range exceeding 80%, and the stock has endured a historic drawdown of nearly 80%, highlighting the high‑risk nature of the equity. Fundamental metrics are equally concerning: revenue is contracting by over 30%, gross margins sit at a meager 5%, and operating margins are deeply negative, while free cash flow is barely positive. The forward P/E of 34 far outstrips the industry average of 17, and a discounted cash‑flow model values the company at roughly $0.04 per share, implying severe overvaluation at current levels. The balance sheet shows a debt‑to‑equity ratio above 2.5, indicating leverage stress, and the company pays no dividend, eliminating any yield cushion. Regulatory exposure in China and the reliance on telecom services amplify sector‑specific risks, while the Singapore base adds a layer of geographic concentration. Despite a modest market cap of $62 million, liquidity is thin, with average volumes well below recent trading activity. In this context, the stock appears positioned for continued pressure unless a material operational turnaround occurs.
Given the confluence of bearish technical signals, deteriorating fundamentals, and a valuation gap that suggests the market is pricing in future recovery that is not yet evident, investors should approach FNGR with caution. The high volatility, leverage, and regulatory headwinds further dampen the outlook, making defensive positioning prudent.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • Decreasing volume indicating weak demand
  • Proximity to support level with limited upside

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Continued revenue decline and negative margins
  • Overvaluation relative to DCF fair value
  • Elevated regulatory and leverage risks

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside if business pivots to higher‑margin services
  • Exposure to growing 5G and data‑analytics markets in China
  • Current financial distress limits confidence in turnaround

Key Metrics & Analysis

Financial Health

Revenue Growth-32.10%
Profit Margin-16.07%
P/E Ratio34.0
ROE-41.31%
ROA-8.37%
Debt/Equity2.59
P/B Ratio3.8
Op. Cash Flow$-7227133
Free Cash Flow$198.1K
Industry P/E17.3

Technical Analysis

TrendBearish
RSI40.4
Support$0.92
Resistance$1.57
MA 20$1.16
MA 50$1.17
MA 200$1.47
MACDBearish
VolumeDecreasing
Fear & Greed Index78.8

Valuation

Fair Value$0.04
GradeOvervalued
TypeValue

Risk Assessment

Beta1.03
Volatility80.21%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.